Tyde Wellness review

Tyde Wellness describes its role as non-clinical administration, with telehealth provided by Tyde Medical Center. Its public pages identify physician Kelly Kassick as co-founder and chief medical officer. This is more specific than an unnamed network description, but it does not identify the practitioner and pharmacy assigned to every patient. The practice markets weight care alongside menopause and longevity services. Ask who will conduct the assessment and what records or testing are required. The existence of a physician-led service and named leaders does not establish that every advertised medication is appropriate, available or supported for all promoted outcomes.

The current semaglutide one-month page gives a starting purchase figure for a one-month supply, while the homepage advertises a lower starting amount and savings on longer plans. These are different offers rather than proof that the lowest banner is a freely cancelable one-month full-dose price. The product page says the price stays the same at each listed dose level, includes messaging and advertises no separate hidden fees. Obtain the complete selected total, amount charged now, supply, renewal dates and any longer commitment. A one-month supply label alone does not establish a calendar-month charge interval, and normalized comparisons remain unquoted until the agreement settles that distinction.

The one-month product page promises a full refund if the clinician does not approve treatment. That should not be extended into an unconditional refund after every later order, renewal or pharmacy preparation. The homepage and footer promote cancellation and subscription flexibility, but the reviewed current treatment and FAQ pages do not settle the selected longer-plan refund calculation or processing cutoff. Request the actual membership agreement before payment. Confirm whether a displayed saving requires prepayment, installments or a particular commitment and what remains due if treatment changes or stops. Retain the plan confirmation, order-stage details and any cancellation acknowledgment.

The pharmacy-partners page names Belmar, Casa Pharma, Olympia, Red Rock Home Pharmacy and Beaker with contact details and locations. It says the actual selection depends on location, prescription and regulatory requirements. Those are company disclosures, not an individual license check or proof that each listed facility will dispense the same preparation. Obtain the actual dispensing name and verify its authorization for the patient’s address. The page’s claims about registration and quality standards do not make a compounded drug FDA-approved. A formulation should not be presumed appropriate solely because an ingredient is familiar, the active molecule appears in a brand or a clinician writes a prescription.

Clinical and shipping timelines are estimates rather than guaranteed outcomes. The one-month page promotes intake review within a few hours, while its delivery FAQ describes shipment one to two business days after approval followed by two-day express transit. That does not establish delivery two days after checkout. The general FAQ says evaluation is typically through a secure video visit, so an online quiz need not be the entire assessment. It lists nationwide service coverage while requiring the patient’s physical location to be a licensed state. Particular medicines, tests and pharmacy arrangements can impose further limits even where the general platform is available.

Menopause and longevity care need product-specific clarification rather than assumptions carried over from weight plans. Confirm the exact hormone, route, approved versus compounded status, laboratory schedule and separate testing cost. For a peptide or alternate-route preparation, ask what human outcome evidence and qualifying access conditions apply. A website listing is not proof of routine authorization, and a topical formulation should not be treated as having the same risks or requirements as an injectable one. Likewise, the brand-drug weight-loss trials cited on Tyde’s GLP-1 pages are not trials of every compounded product or microdose schedule. Nutrition and coaching are service components, rather than evidence that each patient will reproduce the advertised results.